In vivo studies have demonstrated enhanced expression of activated NOTCH1 in the airway of patients with COPD [19] and altered expression of specific Notch ligands, receptors and downstream effectors in the small airway epithelium of smokers and COPD smokers relative to healthy controls [36]. This evidence concerns the gene NOTCH1 and chronic obstructive pulmonary disease.